Asymchem’s breadth of capabilities spans conventional batch manufacturing, and we are a world leader in green chemistry. Our scientists excel in the creation and manufacture of enzymes for use in bio-catalysis, and the development of practical continuous flow technologies for commercialization. In addition to strong supply chain relationships, Asymchem maintains a dedicated facility for the in-house production of raw materials and regulatory starting materials to better control quality, costs and lead times.

Asymchem is a global CDMO that has consistently innovated and invested in new technologies to stay on the forefront of trends in both R&D and production since its inception more than 20 years ago. As a result, Asymchem is well-positioned and structured to be a true global partner in drug development and manufacturing for pharmaceutical and biotech companies by offering integrated solutions across all stages of drug development and into commercialization.

Asymchem has a unit dedicated to preclinical and clinical studies supporting IND filings to bring a drug candidate to Phase I. Once a project reaches Phase II, Asymchem will assign a dedicated group that is familiar with validation and commercialization to guide the project through Phase III until turning the project over to Operations and QA for commercial production.

Asymchem’s breadth of capabilities spans conventional batch manufacturing, and we are a world leader in green chemistry. Our scientists excel in the creation and manufacture of enzymes for use in bio-catalysis, and the development of practical continuous flow technologies for commercialization. In addition to strong supply chain relationships, Asymchem maintains a dedicated facility for the in-house production of raw materials and regulatory starting materials to better control quality, costs and lead times.

We have a consistently demonstrated ability to meet project deadlines and achieve commercialization success, while exemplifying the long-term financial stability critical to project continuity and achievement. Our work has frequently won us “most valuable partner” and “strategic partner” recognition from major pharma and leading biotech companies.

Asymchem maintains an impeccable quality record and positive regulatory and environmental compliance history, with 30 successful USFDA, NMPA, TGA, MFDS inspections. Projects are handled at high standards of safety and environmental responsibility.

Asymchem Inc. is a subsidiary of the Asymchem Group, headquartered in Tianjin, P. R. China. Asymchem Group is a publicly traded company on the Shenzhen Stock Exchange (stock code 002821.SZ).